Evidence map›Paper›PMID 21660601›Full record

ArticleJournal of neurovirology2011

Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling.

Amy D Paulino, Kiren Ubhi, Edward Rockenstein, Anthony Adame, Leslie Crews, Scott Letendre, Ronald Ellis, Ian P Everall, Igor Grant, Eliezer Masliah

RetractedAbstract readRetracted Publication
In one paragraph

Article in Journal of neurovirology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Neuroimmune modulation in liver pathophysiology.Journal of neuroinflammation · 2024
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. HCV Extrahepatic Manifestations.Journal of clinical and translational hepatology · 2019
    Review
  8. Review
  9. Review
  10. Hepatitis C Virus Infection in the Older Patient.Infectious disease clinics of North America · 2017
    Review
  11. Review
  12. Article
  13. Systemic manifestations of hepatitis C infection.Infectious agents and cancer · 2016
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Amy D PaulinoDepartment of Neurosciences, University of California San Diego, La Jolla, CA 92093-0624, USA.
Kiren Ubhi
Edward Rockenstein
Anthony Adame
Leslie Crews
Scott Letendre
Ronald Ellis
Ian P Everall
Igor Grant
Eliezer Masliah
University of California, San Diego · US

Funding

STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DAVID J MOORE · 2001 to 2026
$50.4M
NEUROMOTORP01DA012065 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JERNIGAN, TERRY L. · 1999 to 2009
$17.8M
NEUROAIDS TISSUE NETWORKR24MH059745 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 1998 to 2007
$13.2M
Mechanisms of Neuroprotection in HIV EncephalitisR01MH062962 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MASLIAH, ELIEZER · 2002 to 2016
$5.2M
NIDA NIH HHS DA12065NIDA NIH HHS P01 DA012065NIMH NIH HHS MH059745NIMH NIH HHS MH62512NIMH NIH HHS MH62962NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH062962NIMH NIH HHS R24 MH059745
6 · The paper itself

Abstract

Hepatitis C virus (HCV) infection is a serious problem among those co-infected with human immunodeficiency virus; however, its impact in the central nervous system (CNS) remains unclear. This study aimed to investigate the mechanisms underlying HCV core protein-mediated neurodegeneration. Analysis of human HCV seropositive cases demonstrated widespread damage to neuronal dendritic processes and sustained activation of extracellular signal-related kinase (ERK); analogous pathologies were observed in wild type injected with HCV core protein into the hippocampus. In vitro analysis in neuronal cells exposed to HCV core demonstrated retraction of the neuronal processes in an ERK/Signal Transducer and Activator of Transcription 3 (STAT3)-dependent manner dependent on toll-like receptor 2 (TLR2) signaling activation. These results indicate that HCV core protein neurotoxicity may be mediated by the sustained activation of ERK/STAT3 via TLR2-IRAK1 signaling pathway. These pathways provide novel targets for development of neuroprotective treatments for HCV involvement of the CNS.

Indexed as

HepacivirusAdultAnimalsBlotting, WesternCoinfectionFemaleGene SilencingHepatitis CHippocampusHIVHIV InfectionsHumansImmunohistochemistryInjectionsInterleukin-1 Receptor-Associated KinasesMaleInterleukin-1 Receptor-Associated KinasesIRAK1 protein, humanMAP Kinase Kinase Kinasesnucleocapsid protein, Hepatitis C virusRNA, Small InterferingSTAT3 protein, humanSTAT3 Transcription FactorToll-Like Receptor 2Viral Core Proteins

Identifiers

PMID21660601
PMCPMC3919659
OpenAlexW2009910720

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.